PCN81 COST-EFFECTIVENESS ANALYSIS OF THREE STRATEGIES OF ERLOTINIB TREATMENT IN NON0-SMALL-CELL LUNG CANCER-A PROSPECTIVE MULTICENTRIC FRENCH STUDY (ERMETIC)
Abstract
Authors
I Borget J Cadranel A Mauguen B Coudert E Dansin S Friard C Daniel E Quoix J Madelaine A Madroszyk F Morin JP Pignon C Chouaid